Published in Gut on March 01, 2008
Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell (2015) 3.13
The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications. J Gastroenterol (2014) 2.32
Phages in nature. Bacteriophage (2011) 2.00
Genomic approaches to studying the human microbiota. Nature (2012) 2.00
Resident viruses and their interactions with the immune system. Nat Immunol (2013) 1.58
'Blooming' in the gut: how dysbiosis might contribute to pathogen evolution. Nat Rev Microbiol (2013) 1.45
Diversity and abundance of single-stranded DNA viruses in human feces. Appl Environ Microbiol (2011) 1.27
Kingdom-agnostic metagenomics and the importance of complete characterization of enteric microbial communities. Gastroenterology (2014) 1.16
Study of the viral and microbial communities associated with Crohn's disease: a metagenomic approach. Clin Transl Gastroenterol (2013) 1.06
Movers and shakers: influence of bacteriophages in shaping the mammalian gut microbiota. Gut Microbes (2012) 1.06
Bacteriophages: an underestimated role in human and animal health? Front Cell Infect Microbiol (2014) 1.02
The microbial basis of inflammatory bowel diseases. J Clin Invest (2014) 1.01
The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease? Therap Adv Gastroenterol (2013) 1.00
The human gut mobile metagenome: a metazoan perspective. Gut Microbes (2011) 0.99
The central role of the gut microbiota in chronic inflammatory diseases. J Immunol Res (2014) 0.99
Nutrient-sensing mechanisms in the gut as therapeutic targets for diabetes. Diabetes (2013) 0.97
Genome signature-based dissection of human gut metagenomes to extract subliminal viral sequences. Nat Commun (2013) 0.97
Comparative (meta)genomic analysis and ecological profiling of human gut-specific bacteriophage φB124-14. PLoS One (2012) 0.96
The human gut virome: a multifaceted majority. Front Microbiol (2015) 0.95
Altered oral viral ecology in association with periodontal disease. MBio (2014) 0.95
Gut microbial communities modulating brain development and function. Gut Microbes (2012) 0.90
Gut inflammation and immunity: what is the role of the human gut virome? Mediators Inflamm (2015) 0.87
Novel perspectives on therapeutic modulation of the gut microbiota. Therap Adv Gastroenterol (2016) 0.86
The Gut Microbiota in Immune-Mediated Inflammatory Diseases. Front Microbiol (2016) 0.84
Klebsiella pneumoniae subsp. pneumoniae-bacteriophage combination from the caecal effluent of a healthy woman. PeerJ (2015) 0.83
Modeling the infection dynamics of bacteriophages in enteric Escherichia coli: estimating the contribution of transduction to antimicrobial gene spread. Appl Environ Microbiol (2014) 0.82
Mucosal Interactions between Genetics, Diet, and Microbiome in Inflammatory Bowel Disease. Front Immunol (2016) 0.82
Ecological basis for rational phage therapy. Acta Naturae (2010) 0.81
Evolutionary, ecological and biotechnological perspectives on plasmids resident in the human gut mobile metagenome. Bioeng Bugs (2012) 0.80
The gut microbiota and inflammatory bowel diseases. Transl Res (2016) 0.80
Bacteriophages and genetic mobilization in sewage and faecally polluted environments. Microb Biotechnol (2011) 0.80
Serum Levels of Lipopolysaccharide and 1,3-β-D-Glucan Refer to the Severity in Patients with Crohn's Disease. Mediators Inflamm (2015) 0.80
Long-term changes of bacterial and viral compositions in the intestine of a recovered Clostridium difficile patient after fecal microbiota transplantation. Cold Spring Harb Mol Case Stud (2016) 0.80
Emerging Concepts on the Gut Microbiome and Multiple Sclerosis. J Interferon Cytokine Res (2016) 0.79
Involvement of the mannose receptor and p38 mitogen-activated protein kinase signaling pathway of the microdomain of the integral membrane protein after enteropathogenic Escherichia coli infection. Infect Immun (2012) 0.79
Infectious etiopathogenesis of Crohn's disease. World J Gastroenterol (2014) 0.79
Optimizing protocols for extraction of bacteriophages prior to metagenomic analyses of phage communities in the human gut. Microbiome (2015) 0.78
Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease. World J Gastroenterol (2015) 0.78
The microbiota in inflammatory bowel disease: current and therapeutic insights. J Inflamm Res (2017) 0.75
The Janus-Face of Bacteriophages across Human Body Habitats. PLoS Pathog (2016) 0.75
Clostridium difficile Infection: A Rarity in Patients Receiving Chronic Antibiotic Treatment for Crohn's Disease. Inflamm Bowel Dis (2016) 0.75
Ménage à trois in the human gut: interactions between host, bacteria and phages. Nat Rev Microbiol (2017) 0.75
Dysbiosis as a prerequisite for IBD. Gut (2004) 1.93
Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol (1999) 16.09
Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut (2005) 10.95
Proteorhodopsin phototrophy in the ocean. Nature (2001) 5.73
Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut (2003) 5.19
Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis (2009) 4.72
European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut (2006) 3.59
The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol (2009) 3.58
ARSACS, a spastic ataxia common in northeastern Québec, is caused by mutations in a new gene encoding an 11.5-kb ORF. Nat Genet (2000) 3.17
Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy. Gastroenterology (2000) 2.78
Natural history of human immunodeficiency virus type 1 infection in children: a five-year prospective study in Rwanda. Mother-to-Child HIV-1 Transmission Study Group. Pediatrics (1999) 2.69
Postnatal transmission of HIV from mother to child. Lancet (1987) 2.60
Insect immunity: isolation from immune blood of the dipteran Phormia terranovae of two insect antibacterial peptides with sequence homology to rabbit lung macrophage bactericidal peptides. Proc Natl Acad Sci U S A (1989) 2.49
Fusobacterium prausnitzii and related species represent a dominant group within the human fecal flora. Syst Appl Microbiol (2001) 2.23
Infective and anti-infective properties of breastmilk from HIV-1-infected women. Lancet (1993) 2.18
Comparative study of bacterial groups within the human cecal and fecal microbiota. Appl Environ Microbiol (2001) 2.17
Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge. J Clin Microbiol (2005) 2.16
European evidence-based Consensus on the management of ulcerative colitis: Current management. J Crohns Colitis (2008) 2.14
Acquired immunodeficiency syndrome in Rwanda. Lancet (1984) 2.05
Demonstration of safety of probiotics -- a review. Int J Food Microbiol (1998) 2.02
Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept. Diabetologia (2011) 2.00
Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease. Aliment Pharmacol Ther (2006) 1.97
A comparison of methods for counting viruses in aquatic systems. Appl Environ Microbiol (2000) 1.89
Pharmacokinetics of Lactobacillus plantarum NCIMB 8826, Lactobacillus fermentum KLD, and Lactococcus lactis MG 1363 in the human gastrointestinal tract. Aliment Pharmacol Ther (2000) 1.88
Recovery and phylogenetic analysis of archaeal rRNA sequences from continental shelf sediments. FEMS Microbiol Lett (1998) 1.84
Natural resistance to intracellular infections: Nramp1 encodes a membrane phosphoglycoprotein absent in macrophages from susceptible (Nramp1 D169) mouse strains. J Immunol (1996) 1.78
Molecular characterization of a 23-kilodalton major antigen secreted by Toxoplasma gondii. Proc Natl Acad Sci U S A (1989) 1.73
Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis (2003) 1.72
Highlighting new phylogenetic specificities of Crohn's disease microbiota. Inflamm Bowel Dis (2010) 1.70
Association of chronic interstitial cystitis, protein-losing enteropathy and paralytic ileus with seronegative systemic lupus erythematosus: case report and review of the literature. Clin Nephrol (1992) 1.66
Community-acquired bacteraemia in African children. Lancet (1987) 1.61
Long-term outcome of patients with gastrointestinal bleeding of obscure origin explored by push enteroscopy. Endoscopy (2002) 1.60
Right colonic involvement is associated with severe forms of ischemic colitis and occurs frequently in patients with chronic renal failure requiring hemodialysis. Am J Gastroenterol (2000) 1.59
Improved clinical tolerance to chronic lactose ingestion in subjects with lactose intolerance: a placebo effect? Gut (1997) 1.55
Survival of bifidobacteria ingested via fermented milk during their passage through the human small intestine: an in vivo study using intestinal perfusion. Am J Clin Nutr (1992) 1.54
Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitis. J Clin Microbiol (2006) 1.53
Molecular scanning of the human PPARa gene: association of the L162v mutation with hyperapobetalipoproteinemia. J Lipid Res (2000) 1.46
Validation of a live animal model for training in endoscopic hemostasis of upper gastrointestinal bleeding ulcers. Endoscopy (2013) 1.46
Cryptosporidium spp., a frequent cause of diarrhea in Central Africa. J Clin Microbiol (1984) 1.44
Molecular biological methods for studying the gut microbiota: the EU human gut flora project. Br J Nutr (2002) 1.39
[Code of professional ethics in clinical research]. Gastroenterol Clin Biol (2001) 1.39
Review article: gut flora and inflammatory bowel disease. Aliment Pharmacol Ther (2004) 1.36
Prevention of mother-to-child transmission of HIV in developing countries: recommendations for practice. The Ghent International Working Group on Mother-To-Child Transmission of HIV. Health Policy Plan (2000) 1.34
A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome in Africa. Am J Ophthalmol (1985) 1.33
Neurodevelopmental testing of children born to human immunodeficiency virus type 1 seropositive and seronegative mothers: a prospective cohort study in Kigali, Rwanda. Pediatrics (1993) 1.33
Effects of gold salts and prednisolone on inflammatory cells. II. Suppression of inflammation and phagocytosis in the rat. Ann Rheum Dis (1973) 1.33
A computer-controlled system to simulate conditions of the large intestine with peristaltic mixing, water absorption and absorption of fermentation products. Appl Microbiol Biotechnol (1999) 1.31
Breastfeeding and hospital mortality in children in Rwanda. Lancet (1981) 1.30
Molecular comparison of dominant microbiota associated with injured versus healthy mucosa in ulcerative colitis. Gut (2007) 1.29
Human immunodeficiency virus and malaria in a representative sample of childbearing women in Kigali, Rwanda. J Infect Dis (1991) 1.29
Seroincidence of HIV-1 infection in African women of reproductive age: a prospective cohort study in Kigali, Rwanda, 1988-1992. AIDS (1994) 1.28
Short-chain fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans. J Nutr (1999) 1.26
On the safety of lactic acid bacteria from food. Int J Food Microbiol (1995) 1.25
Fecal recovery in humans of viable Bifidobacterium sp ingested in fermented milk. Gastroenterology (1992) 1.24
Molecular phylogenetic profiling of prokaryotic communities in guts of termites with different feeding habits. FEMS Microbiol Ecol (2001) 1.22
Reducing weight increases postural stability in obese and morbid obese men. Int J Obes (Lond) (2006) 1.22
The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodies. Aliment Pharmacol Ther (2010) 1.18
Interrelations between populations of methanogenic archaea and sulfate-reducing bacteria in the human colon. FEMS Microbiol Lett (1992) 1.18
Genomic structure, promoter sequence, and induction of expression of the mouse Nramp1 gene in macrophages. Genomics (1995) 1.18
Gut microbiota and gastrointestinal health: current concepts and future directions. Neurogastroenterol Motil (2013) 1.13
Cloning and nucleotide sequence of the phosphoenolpyruvate carboxylase-coding gene of Corynebacterium glutamicum ATCC13032. Gene (1989) 1.11
Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine. Gut (2007) 1.09
Altered secretion in the right colon during ulcerative colitis: is it due to disease or to 5-ASA? Neurogastroenterol Motil (2013) 1.09
Casein peptide release and passage to the blood in humans during digestion of milk or yogurt. Biochimie (1998) 1.07
Phage bacteriolysis, protistan bacterivory potential, and bacterial production in a freshwater reservoir: coupling with temperature. Microb Ecol (2005) 1.07
Whole exome sequencing unravels disease-causing genes in consanguineous families in Qatar. Clin Genet (2013) 1.06
Lactose intolerance. J Am Coll Nutr (2000) 1.06
Ecological study of a bioaugmentation failure. Environ Microbiol (2000) 1.05
High-resolution linkage map in the proximity of the host resistance locus Cmv1. Genomics (1997) 1.05
The contribution of lysine-36 to catalysis by human myo-inositol monophosphatase. Biochemistry (1996) 1.04
Trophic interactions between viruses, bacteria and nanoflagellates under various nutrient conditions and simulated climate change. Environ Microbiol (2011) 1.04
Protozoan bacterivory and Escherichia coli survival in drinking water distribution systems. Appl Environ Microbiol (1998) 1.03
Vascular aphasias: main characteristics of patients hospitalized in acute stroke units. Stroke (2002) 1.02
Mother-to-infant transmission of human immunodeficiency virus by breast milk: presumed innocent or presumed guilty? Clin Infect Dis (1992) 1.02
Autoimmunity: from physiology to pathology. Natural antibodies, mucosal immunity and development of B cell repertoire. Folia Biol (Praha) (1992) 1.00
Four years of natural history of HIV-1 infection in african women: a prospective cohort study in Kigali (Rwanda), 1988-1993. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.00
Plexitis as a predictive factor of early postoperative clinical recurrence in Crohn's disease. Gut (2009) 0.99
Spectrum and frequency of illness presenting to a pediatric emergency department. Acta Clin Belg (2006) 0.99
A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome. Gastroenterol Clin Biol (2008) 0.98
Mast cell numbers in incisional wounds in rat skin as a function of distance, time and treatment. Br J Dermatol (1983) 0.98
Severe multiresistant Salmonella typhimurium systemic infections in Central Africa--clinical features and treatment in a paediatric department. J Antimicrob Chemother (1984) 0.97
Clinical trial: Preliminary efficacy and safety study of a new Budesonide-MMX® 9 mg extended-release tablets in patients with active left-sided ulcerative colitis. J Crohns Colitis (2009) 0.96
Mucolipidosis II: a single causal mutation in the N-acetylglucosamine-1-phosphotransferase gene (GNPTAB) in a French Canadian founder population. Clin Genet (2008) 0.95
Gastrointestinal tract and the elderly: functional foods, gut microflora and healthy ageing. Dig Liver Dis (2002) 0.95
Gastroileal nitrogen and electrolyte movements after bovine milk ingestion in humans. Am J Clin Nutr (1992) 0.95
Ruminococcus hydrogenotrophicus sp. nov., a new H2/CO2-utilizing acetogenic bacterium isolated from human feces. Arch Microbiol (1996) 0.94
Evidence for transplacental transmission of the current wild-type strain of bluetongue virus serotype 8 in cattle. Vet Rec (2008) 0.94
Perivasculitis of the retinal vessels as an important sign in children with AIDS-related complex. Am J Ophthalmol (1985) 0.94